Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Preclinical murine tumor models: a structural and functional perspective

Journal article

Guerin MV. et al, (2020), eLife, 9

Is There a Clinical Future for IDO1 Inhibitors After the Failure of Epacadostat in Melanoma?

Chapter

Van den Eynde BJ. et al, (2020), ANNUAL REVIEW OF CANCER BIOLOGY, VOL 4, 4, 241 - 256

Inhibition of tryptophan-dioxygenase activity increases the antitumor efficacy of immune checkpoint inhibitors

Journal article

Schramme F. et al, (2019), Cancer Immunology Research, canimm.0041.2019 - canimm.0041.2019

NO• /RUNX3/Kynurenine Metabolic Signaling Enhances Disease Aggressiveness in Pancreatic Cancer.

Journal article

Wang L. et al, (2019), International journal of cancer

Understanding the tumor immune escape and the immune modulatory function of cancer stem cells

Conference paper

Zhu J. et al, (2019), EUROPEAN JOURNAL OF IMMUNOLOGY, 49, 1243 - 1243

Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism.

Journal article

Zhu J. et al, (2019), Cancer Immunol Immunother, 68, 835 - 847

The Vacuolar Pathway of Long Peptide Cross-Presentation Can Be TAP Dependent.

Journal article

Ma W. et al, (2019), J Immunol, 202, 451 - 459

Identifying Antigens Recognized by Cytolytic T Lymphocytes on Tumors.

Chapter

Vigneron N. et al, (2019), 1988, 159 - 186

Induction of tryptophan 2,3-dioxygenase expression in human monocytic leukemia/lymphoma cell lines THP-1 and U937

Journal article

Hoffmann D. et al, (2019), International Journal of Tryptophan Research, 12, 117864691989173 - 117864691989173

Immunosuppression mediated by enzymes that degrade tryptophan

Conference paper

Van den Eynde B., (2018), TOXICOLOGY LETTERS, 295, S19 - S19

Single cell RNA sequencing reveals AML immunoediting under pressure from engineered T cell therapy

Conference paper

Paulson KG. et al, (2018), CANCER RESEARCH, 78

Load More